Pro Medicus Limited (ASX: PME) - Share Price
Current share price for PME : $209.650 3.72 (1.81%)+
Pro Medicus Limited (PME), an ASX-listed company, is involved in the development and supply of healthcare imaging software, Radiology Information System (RIS) software and services to hospitals, diagnostic imaging groups and other related health entities in Australia, North America and Europe.
PME General Information +
| ASX Code | PME |
| Website | http://www.promed.com.au |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 21,902 |
| PME Share Price | $209.650 |
| Day High | $212.300 |
| Day Low | $202.010 |
| Last Close | $205.930 |
| PME Share Price Movement | $3.72 ( 1.81% ) |
Prices as at 16:40, 3 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Pro Medicus Limited (PME) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 32¢ | 100% | 26 Feb 2026 | 20 Mar 2026 | - | - | - |
| HFResult | 30¢ | 100% | 3 Sep 2025 | 25 Sep 2025 | - | - | - |
| Result | 25¢ | 100% | 27 Feb 2025 | 21 Mar 2025 | - | - | - |
See all dividends from Pro Medicus Limited (PME) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Pro Medicus Limited (PME) price-sensitive announcements
PME - PME signs HoA Echo IQ Finance Facility & Reseller Agreement
Pro Medicus Limited, an Australian health imaging company, announced on 25 June 2026 that
Pro Medicus Limited (PME)
25 Jun 2026 | 9:07 AM
25 Jun 2026 | 9:07 AM
PME - EIQ: Binding HOA secured with Pro Medicus Limited
Echo IQ Limited has secured a binding Heads of Agreement (HOA) with Pro Medicus Limited to
Pro Medicus Limited (PME)
25 Jun 2026 | 8:51 AM
25 Jun 2026 | 8:51 AM
PME - S&P DJI Announces June 2026 Quarterly Rebalance
S&P Dow Jones Indices has announced the June 2026 quarterly rebalance of the S&P/ASX indic
Pro Medicus Limited (PME)
5 Jun 2026 | 5:12 PM
5 Jun 2026 | 5:12 PM
PME - PME signs 5-year, A$16M contract renewal with OSU
Pro Medicus Limited, through its U.S. subsidiary Visage Imaging, Inc., has signed a 5-year
Pro Medicus Limited (PME)
4 Jun 2026 | 8:24 AM
4 Jun 2026 | 8:24 AM
Pro Medicus Limited (PME) Recent ASX Announcements
PME Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $113.01 | $108.14 | 9.80% | 263.74 | 54.00 | 0.19% | 100.0% |
| 2025F | $102.88 | $98.45 | 23.80% | 289.70 | 49.00 | 0.17% | 100.0% |
| 2024A | $83.21 | $79.51 | 36.80% | 116.74 | 40.00 | 0.43% | 100.0% |
PME Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| 4DMedical Limited (4DX) | $2,414M | 0.3304 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $21,194M | 0.3919 | 0.2545 | 0.2962 | 184.2598 | 146.8795 | 113.3162 | 0.27% | 0.35% | 0.45% |
PME Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 3.00 | 149.10 | 83.70 | 5.42 |
| Market | 0.28 | 13.10 | 1.14 | 0.68 |
| Sector | 0.67 | 20.50 | 1.63 | 2.64 |
PME Directors
| Name | Position | Start Date |
|---|---|---|
| Dr Sam Aaron Hupert | Chief Executive Officer, Managing Director | 1 Jan 1983 |
| Mr Anthony Barry Hall | Executive Director, Technology Director | 1 Jan 1983 |
| Mr Peter Terence Kempen | Non-Executive Chairman, Non-Executive Director | 12 Mar 2008 |
| Ms Alice Joan Morrice Williams | Non-Executive Director | 1 Sep 2021 |
| Ms Deena Robyn Shiff | Non-Executive Director | 1 Aug 2020 |
| Mr Anthony James Glenning | Non-Executive Director | 1 May 2016 |
| Dr Leigh Bernard Farrell | Non-Executive Director | 8 Sep 2017 |
Pro Medicus Limited (PME) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 26 Feb 2026 | HALL, Anthony | Buy | Indirect Shares | 8,146 | $122.000 | $993,812.000 |
| 25 Feb 2026 | HALL, Anthony | Buy | Indirect Shares | 9,000 | $114.410 | $1,029,690.000 |
| 24 Feb 2026 | HUPERT, Sam | Buy | Indirect Shares | 4,500 | $108.720 | $489,240.000 |
See all changes in directors' interest & trades for Pro Medicus Limited (PME) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
PME Management
| Name | Position |
|---|---|
| Clayton Hatch | Chief Financial Officer |
| Danny English | Company Secretary |
| Malte Westerhoff | General Manager Europe and Global Chief Technology Officer |
PME Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Pro Medicus Limited (PME). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 24,144,000 (23.12%) | Hall, Anthony Barry |
| 24,137,660 (23.11%) | Sam Aaron Hupert |
PME Calendar of Events
| Date | Event |
|---|---|
| 11 February 2027 | Report (Interim) |
| 13 August 2026 | Report (Annual) |
| 13 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
